Kun‐Pin Hsieh

565 total citations
22 papers, 430 citations indexed

About

Kun‐Pin Hsieh is a scholar working on Cardiology and Cardiovascular Medicine, Family Practice and Oncology. According to data from OpenAlex, Kun‐Pin Hsieh has authored 22 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 5 papers in Family Practice and 3 papers in Oncology. Recurrent topics in Kun‐Pin Hsieh's work include Medication Adherence and Compliance (5 papers), Bipolar Disorder and Treatment (3 papers) and Pregnancy and Medication Impact (2 papers). Kun‐Pin Hsieh is often cited by papers focused on Medication Adherence and Compliance (5 papers), Bipolar Disorder and Treatment (3 papers) and Pregnancy and Medication Impact (2 papers). Kun‐Pin Hsieh collaborates with scholars based in Taiwan, United Kingdom and United States. Kun‐Pin Hsieh's co-authors include Yi‐Hsin Yang, Li‐Chia Chen, Kwok‐Leung Cheung, Ying‐Chi Lin, Chau‐Chyun Sheu, Chao-Sung Chang, Jung‐San Chang, Ping‐Hsun Wu, Chia‐Chi Wang and Sheau‐Fang Yang and has published in prestigious journals such as PLoS ONE, Scientific Reports and The British Journal of Psychiatry.

In The Last Decade

Kun‐Pin Hsieh

21 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kun‐Pin Hsieh Taiwan 12 78 64 63 53 51 22 430
Ylva Haasum Sweden 9 76 1.0× 50 0.8× 57 0.9× 57 1.1× 7 0.1× 10 603
Johannes Aufenanger Germany 14 104 1.3× 70 1.1× 28 0.4× 58 1.1× 33 0.6× 38 584
Eun Sil Lee South Korea 13 101 1.3× 31 0.5× 26 0.4× 67 1.3× 16 0.3× 59 580
Ya-Hui Hsu Taiwan 9 38 0.5× 14 0.2× 14 0.2× 91 1.7× 6 0.1× 17 351
Xander M.R. van Wijk United States 14 163 2.1× 56 0.9× 11 0.2× 28 0.5× 49 1.0× 45 557
Arun S. Menon India 14 52 0.7× 57 0.9× 11 0.2× 25 0.5× 8 0.2× 51 536
Laurenz Schmitt Germany 17 72 0.9× 80 1.3× 12 0.2× 61 1.2× 20 0.4× 41 702
Xueying Li China 11 72 0.9× 249 3.9× 63 1.0× 54 1.0× 3 0.1× 47 540
Raffaele Pellegrino Italy 15 67 0.9× 121 1.9× 28 0.4× 58 1.1× 16 0.3× 47 556
Fei-Li Zhao China 13 42 0.5× 32 0.5× 62 1.0× 23 0.4× 8 0.2× 29 474

Countries citing papers authored by Kun‐Pin Hsieh

Since Specialization
Citations

This map shows the geographic impact of Kun‐Pin Hsieh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun‐Pin Hsieh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun‐Pin Hsieh more than expected).

Fields of papers citing papers by Kun‐Pin Hsieh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun‐Pin Hsieh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun‐Pin Hsieh. The network helps show where Kun‐Pin Hsieh may publish in the future.

Co-authorship network of co-authors of Kun‐Pin Hsieh

This figure shows the co-authorship network connecting the top 25 collaborators of Kun‐Pin Hsieh. A scholar is included among the top collaborators of Kun‐Pin Hsieh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun‐Pin Hsieh. Kun‐Pin Hsieh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Lee, Chia‐Han, Ming‐Ju Tsai, Jung‐San Chang, et al.. (2022). Proton pump inhibitors reduce the survival of advanced lung cancer patients with therapy of gefitinib or erlotinib. Scientific Reports. 12(1). 7002–7002. 10 indexed citations
4.
5.
Chen, Fang‐Ming, et al.. (2022). Investigating the effectiveness of adjuvant therapy for patients with hormone receptor-positive ductal carcinoma in situ. PLoS ONE. 17(1). e0262934–e0262934. 4 indexed citations
6.
Hsieh, Hui‐Min, et al.. (2021). Importance of medication adherence in treatment needed diabetic retinopathy. Scientific Reports. 11(1). 19100–19100. 18 indexed citations
7.
Yang, Yi‐Hsin, et al.. (2021). Cardiovascular events in patients with chronic myeloid leukaemia treated with tyrosine kinase inhibitors in Taiwan: a nationwide population-based study. European Journal of Preventive Cardiology. 29(9). 1312–1321. 3 indexed citations
8.
Hsieh, Kun‐Pin, et al.. (2021). Comparing survival and subsequent treatment of first-line tyrosine kinase inhibitors in patients of advanced lung adenocarcinoma with epidermal growth factor receptor mutation. Journal of the Formosan Medical Association. 121(1). 170–180. 9 indexed citations
9.
Lin, Ying‐Chi, et al.. (2020). Is colistin-associated acute kidney injury clinically important in adults? A systematic review and meta-analysis. International Journal of Antimicrobial Agents. 55(3). 105889–105889. 31 indexed citations
10.
Hsieh, Kun‐Pin, et al.. (2017). Role of cyclooxygenase‐2 inhibitors in the survival outcome of colorectal cancer patients: A population‐based cohort study. The Kaohsiung Journal of Medical Sciences. 33(6). 308–314. 15 indexed citations
11.
Hsieh, Kun‐Pin, et al.. (2016). Use of lithium and cancer risk in patients with bipolar disorder: population-based cohort study. The British Journal of Psychiatry. 209(5). 393–399. 56 indexed citations
12.
Hsieh, Kun‐Pin, et al.. (2016). Antipsychotic medications and dental caries in newly diagnosed schizophrenia: A nationwide cohort study. Psychiatry Research. 245. 45–50. 20 indexed citations
13.
Hsieh, Kun‐Pin, et al.. (2016). Determination of deferasirox in human plasma by short-end injection and sweeping with a field-amplified sample stacking and micellar electrokinetic chromatography. Journal of Pharmaceutical and Biomedical Analysis. 131. 497–502. 19 indexed citations
14.
Chang, Yang‐Pei, Chih‐Jen Yang, A‐Ching Chao, et al.. (2016). Risk factors for pneumonia among patients with Parkinson's disease: a Taiwan nationwide population-based study. Neuropsychiatric Disease and Treatment. 1037–1037. 16 indexed citations
15.
Wu, Ping‐Hsun, Yi‐Ting Lin, Kun‐Pin Hsieh, Hung‐Yi Chuang, & Chau‐Chyun Sheu. (2015). Hepatitis C Virus Infection Is Associated With an Increased Risk of Active Tuberculosis Disease. Medicine. 94(33). e1328–e1328. 32 indexed citations
16.
Chen, Chung‐Hwan, et al.. (2015). Rivaroxaban in preventing venous thromboembolism after arthroplastic surgery in Taiwan. The Kaohsiung Journal of Medical Sciences. 31(10). 534–539. 4 indexed citations
17.
Wang, Chia‐Chi, et al.. (2015). Topical simvastatin promotes healing of Staphylococcus aureus‐contaminated cutaneous wounds. International Wound Journal. 13(6). 1150–1157. 38 indexed citations
18.
Hsieh, Kun‐Pin, Li‐Chia Chen, Kwok‐Leung Cheung, & Yi‐Hsin Yang. (2015). Risks of nonadherence to hormone therapy in Asian women with breast cancer. The Kaohsiung Journal of Medical Sciences. 31(6). 328–334. 13 indexed citations
19.
Hsieh, Kun‐Pin, Li‐Chia Chen, Kwok‐Leung Cheung, Chao-Sung Chang, & Yi‐Hsin Yang. (2014). Interruption and Non-Adherence to Long-Term Adjuvant Hormone Therapy Is Associated with Adverse Survival Outcome of Breast Cancer Women - An Asian Population-Based Study. PLoS ONE. 9(2). e87027–e87027. 57 indexed citations
20.
Christ, George J., Nancy S. Day, Weixin Zhao, et al.. (2001). Bladder injection of “naked”hSlo/pcDNA3 ameliorates detrusor hyperactivity in obstructed rats in vivo. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 281(5). R1699–R1709. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ylva Haasum Breakdown of academic impact, for papers by Johannes Aufenanger Breakdown of academic impact, for papers by Eun Sil Lee Breakdown of academic impact, for papers by Ya-Hui Hsu Breakdown of academic impact, for papers by Xander M.R. van Wijk Breakdown of academic impact, for papers by Arun S. Menon Breakdown of academic impact, for papers by Laurenz Schmitt Breakdown of academic impact, for papers by Xueying Li Breakdown of academic impact, for papers by Raffaele Pellegrino Breakdown of academic impact, for papers by Fei-Li Zhao
Rankless by CCL
2026